You can buy or sell ANIX and other stocks, options, ETFs, and crypto commission-free!
Anixa Biosciences, Inc. Common Stock, also called Anixa Biosciences, is a cancer-focused biotechnology company, which focuses on harnessing the body’s immune system in the fight against cancer. Read More It operates through the following segments: Cancer Diagnostics, Cancer Therapeutics, and Legacy Patent Licensing Activities. Cancer Diagnostic segment develops CchekTM platform, a series of inexpensive non-invasive blood tests for the early detection of solid tumors, which is based on the body’s immune response to the presence of a malignancy. Cancer Therapeutics segment offers chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs which genetically engineer a patient’s own immune cells to fight cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
San Jose, California
52 Week High
52 Week Low
— per share